2-甲基苯乙胺 | 55755-16-3

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-甲基苯乙胺
• 中文别名: 邻甲基苯乙胺；2-(邻甲苯基)乙胺
• 英文名称: 2-methylphenethylamine
• 英文别名: 2-(2-methylphenyl)ethylamine；2-(o-tolyl)ethan-1-amine；2-(o-tolyl)ethanamine；o-methylphenethylamine；1-amino-2-(2-methylphenyl)ethane；2-(2-methylphenyl)ethanamine
• CAS: 55755-16-3
• 化学式: C₉H₁₃N
• mdl: MFCD01310827
• 分子量: 135.209
• InChiKey: OWOUKRYOZIZVFK-UHFFFAOYSA-N

物化性质

• 熔点：
  116°C (estimate)
• 沸点：
  97°C 5mm
• 密度：
  0,96 g/cm3
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  CORROSIVE
• 危险等级：
  8
• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• 海关编码：
  2921499090
• 危险品运输编号：
  2735
• 储存条件：
  存放于阴凉干燥处。

SDS

Name:	2-Methylphenethylamine 97% Material Safety Data Sheet
Synonym:	None Known
CAS:	55755-16-3

Section 1 - Chemical Product MSDS Name:2-Methylphenethylamine 97% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
55755-16-3	2-Methylphenethylamine	97%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Chronic exposure may cause effects similar to those of acute exposure.

---

Section 4 - FIRST AID MEASURES
Eyes: Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give anything by mouth to an unconscious person.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale. Use only in a chemical fume hood. Discard contaminated shoes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 55755-16-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H13N
Molecular Weight: 135.21

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not currently available.
Conditions to Avoid:
No specific conditions to avoid noted.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 55755-16-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Methylphenethylamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: Pseudomonas putida:

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Amines, liquid, corrosive, n.o.s.*
Hazard Class: 8
UN Number: 2735
Packing Group: III
IMO
Shipping Name: Amines, liquid, corrosive, n.o.s.
Hazard Class: 8
UN Number: 2735
Packing Group: III
RID/ADR
Shipping Name: Amines, liquid, corrosive, n.o.s.
Hazard Class: 8
UN Number: 2735
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 55755-16-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 55755-16-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 55755-16-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途：重要的医药中间体

反应信息

• 作为反应物：
  描述：

  2-甲基苯乙胺 在 三氟甲磺酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 3.0h， 生成 5-甲基-3,4-二氢异喹啉-1(2H)-酮
  参考文献：
  名称：

  PARP10细胞活性抑制剂的合理设计。

  摘要：

  聚-ADP-核糖聚合酶（PARP 1-16）已经成为多种细胞过程的主要调节剂。PARPs可以根据其催化聚ADP-核糖基化（PARylation）或单ADP-核糖基化（MARylation）的能力进行分类。尽管人们对催化PARylation（例如PARP1）的PARP的细胞作用了解很多，但基本上不了解催化MARylation（例如PARP10）的PARPs的功能。这在很大程度上是由于缺乏对催化MARylation的单个PARP家族成员具有选择性的小分子抑制剂。在这里，我们描述了PARP10选择性抑制剂的合理设计和合成。使用基于结构的设计，我们针对PARP10烟酰胺结合位点内的疏水子口袋。我们基于3合成了一系列小分子，4-dihydroisoquinolin-1（2H）-one（dq，1）支架，其在C-5和C-6位置包含多个取代基，旨在利用此疏水子口袋。我们发现了一个dq类似物（22），其在C

  DOI：

  10.1021/acsmedchemlett.8b00429
• 作为产物：
  描述：

  methyl-2 β-nitrostyrene 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 生成 2-甲基苯乙胺
  参考文献：
  名称：

  取代的1-（氨基甲基）-2-（芳基乙酰基）-1,2,3,4-四氢异喹啉：一类新型的非常有效的抗伤害药，对kappa和mu阿片受体具有不同程度的选择性。

  摘要：

  这项研究描述了一系列新型取代的1-（氨基甲基）-2-（芳基乙酰基）-1,2,3,4-四氢异喹啉的合成，并讨论了它们对阿片受体的结合亲和力与它们的结构活性关系（SAR）。抗伤害感受力作为生物活性的指标。在异喹啉核的5位上引入羟基取代基产生了一种化合物40，其效力比抗伤害感受的小鼠模型中先前公开的未取代类似物39强2倍。对5-取代基的QSAR分析清楚地表明，抗伤害感受活性与取代基的亲脂性成反比。与未取代的异喹啉39相比，本文所述的取代化合物对κ阿片受体的选择性较低。5-羟基取代的化合物59对kappa阿片受体具有很高的亲和力（Ki kappa = 0.09 nM），Ki mu / Ki kappa之比仅为5。但是，多元线性回归分析表明，抗伤害性与对μ阿片样物质受体的亲和力。另一方面，对κ阿片受体的结合亲和力与抗伤害感受活性之间的相关性具有统计学意义。

  DOI：

  10.1021/jm00094a006

文献信息

• THERAPEUTIC AGENT FOR CEREBRAL INFARCTION
  申请人：Nakao Akira

  公开号：US20120196824A1

  公开（公告）日：2012-08-02

  The invention provides a therapeutic drug for ischemic stroke. The therapeutic drug has the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof, as an active ingredient.

  这项发明提供了一种用于缺血性中风的治疗药物。该治疗药物具有如下式（I）的化学式，其中每个符号如本文所定义，或其药理学上可接受的盐，或其溶剂化物，作为活性成分。
• Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
  申请人：——

  公开号：US20040157849A1

  公开（公告）日：2004-08-12

  Compounds of formula (I) 1 are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

  式（I）的化合物是新颖的VR1拮抗剂，可用于治疗疼痛、炎症性热性过敏、尿失禁和膀胱过度活动。
• Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：US20160095858A1

  公开（公告）日：2016-04-07

  The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R 1 , R 2 , R 3 , W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.

  本发明涉及一种具有以下化学式I的化合物： 或其药用可接受的盐，其中R 1 ，R 2 ，R 3 ，W，X，Y，Z，n，o，p和q在此处定义，用于治疗CFTR介导的疾病，如囊性纤维化。本发明还涉及药物组合物、治疗方法和相关工具包。
• Pd(II)-Catalyzed Amination of C−H Bonds Using Single-Electron or Two-electron Oxidants
  作者：Tian-Sheng Mei、Xisheng Wang、Jin-Quan Yu

  DOI：10.1021/ja904709b

  日期：2009.8.12

  Pd(II)-catalyzed intramolecular amination of arenes is developed using either a one- or two-electron oxidant. The reaction protocol tolerates a wide range of deactivating groups including acetyl, cyano, and nitro groups. This catalytic reaction allows expedient syntheses of broadly useful substituted indolines or indoles.

  使用单电子或双电子氧化剂开发了 Pd(II) 催化的芳烃分子内胺化。该反应方案可耐受多种失活基团，包括乙酰基、氰基和硝基。这种催化反应可以方便地合成广泛有用的取代二氢吲哚或吲哚。
• [EN] TRIAZOLO-PYRIDAZINE COMPOUNDS AND DERIVATIVES THEREOF USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN<br/>[FR] COMPOSES DE TRIAZOLO-PYRIDAZINE ET LEURS DERIVES, DESTINES AU TRAITEMENT DE LA DOULEUR NEUROPATHIQUE
  申请人：MERCK & CO INC

  公开号：WO2005041971A1

  公开（公告）日：2005-05-12

  The present invention is directed to a method of use of triazolo-pyridazine compounds in the treatment of neuropathic pain. The present invention is also directed to the use of triazolo-pyridazine compounds in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, bipolar disorders, and panic, as well as in the treatment of pain, Parkinson’s disease, cognitive dysfunction, epilepsy, circadian rhythm and sleep disorders - such as shift-work induced sleep disorder and jet-lag, drug addiction, drug abuse, drug withdrawal and other diseases. The present invention is also directed to novel triazolo-pyridazine compounds that selectively bind to α2δ-1 subunit of Ca channels.

  本发明涉及一种在治疗神经病性疼痛中使用三唑吡啶化合物的方法。本发明还涉及在治疗精神和情绪障碍，如精神分裂症、焦虑、抑郁、躁郁症和恐慌，以及在治疗疼痛、帕金森病、认知功能障碍、癫痫、昼夜节律和睡眠障碍（如倒班引起的睡眠障碍和时差反应）、药物成瘾、药物滥用、药物戒断和其他疾病中使用三唑吡啶化合物的方法。本发明还涉及选择性结合到Ca通道α2δ-1亚基的新型三唑吡啶化合物。